Clinical Trial Update: Safety and Efficacy Evaluation of Decitabine With R-GDP [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and preliminary efficacy of decitabine in combination with the R-GDP regimen for non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Dacogen (decitabine)
• Gemzar (gemcitabine)
• Rituxan (rituximab)

Snippet

Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd. | Conditions: NHL | Phase 1 | Status: UNKNOWN